Published:
ATS Medical to Participate at the Fourth Annual Collins Stewart Growth Conference
MINNEAPOLIS, July 2 /PRNewswire-FirstCall/ -- ATS Medical, Inc.
(Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery
products, announced today that it will participate at the Collins Stewart LLC
Fourth Annual Growth Conference at the Mandarin Oriental Hotel inNew York
City. Michael Dale, President and CEO of ATS Medical, will present at 4:30
p.m. Eastern Time on Tuesday, July 8, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)
Attendance at the conference is by invitation only. A live audio-only
webcast of the presentation will be broadcast via the Internet. Those
interested in listening to the webcast may access it at ATS Medical's website
at http://www.atsmedical.com. An archived replay of the presentation will also
be available approximately one hour following the live presentation at
http://www.atsmedical.com.
About ATS Medical
ATS Medical, Inc. provides innovative products and services focused on
cardiac surgery. The Company, global in scope, is headquartered in
Minneapolis, Minnesota. More than 150,000 ATS Open Pivot(R) Heart Valves,
which utilize a unique pivot design resulting in exceptional performance and
low risk profile, have been implanted in patients worldwide. The ATS 3f(R)
brand encompasses multiple tissue heart valve product offerings at varying
steps from market introductions to clinical trials to development projects
that incorporate less invasive valve replacement technology. ATS Medical's
focus on serving the cardiac surgery community is further strengthened by
offerings that include ATS Simulus(R) annuloplasty products for heart valve
repair and ATS CryoMaze(TM) surgical ablation products. The ATS Medical web
site is http://www.atsmedical.com.
SOURCE ATS Medical, Inc.
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily News
Tags: Healthcare, Pharmaceuticals, Banking and Finance, Health, minnesota, new york
_ _Is your favorite bookmark site missing?
Ask for it.